Catalyst Wire Dossier Catalyst Wire Dossier

5-ALA

5-aminolevulinic acid
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for 5-ALA, covering 2013-03-20 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma [Phase 2]

See pricing